Correlation Between Mach7 Technologies and Telix Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mach7 Technologies and Telix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mach7 Technologies and Telix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mach7 Technologies and Telix Pharmaceuticals, you can compare the effects of market volatilities on Mach7 Technologies and Telix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mach7 Technologies with a short position of Telix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mach7 Technologies and Telix Pharmaceuticals.
Diversification Opportunities for Mach7 Technologies and Telix Pharmaceuticals
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mach7 and Telix is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Mach7 Technologies and Telix Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telix Pharmaceuticals and Mach7 Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mach7 Technologies are associated (or correlated) with Telix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telix Pharmaceuticals has no effect on the direction of Mach7 Technologies i.e., Mach7 Technologies and Telix Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mach7 Technologies and Telix Pharmaceuticals
Assuming the 90 days trading horizon Mach7 Technologies is expected to under-perform the Telix Pharmaceuticals. In addition to that, Mach7 Technologies is 1.35 times more volatile than Telix Pharmaceuticals. It trades about -0.04 of its total potential returns per unit of risk. Telix Pharmaceuticals is currently generating about 0.15 per unit of volatility. If you would invest 1,774 in Telix Pharmaceuticals on December 5, 2024 and sell it today you would earn a total of 980.00 from holding Telix Pharmaceuticals or generate 55.24% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Mach7 Technologies vs. Telix Pharmaceuticals
Performance |
Timeline |
Mach7 Technologies |
Telix Pharmaceuticals |
Mach7 Technologies and Telix Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mach7 Technologies and Telix Pharmaceuticals
The main advantage of trading using opposite Mach7 Technologies and Telix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mach7 Technologies position performs unexpectedly, Telix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telix Pharmaceuticals will offset losses from the drop in Telix Pharmaceuticals' long position.Mach7 Technologies vs. Resonance Health | Mach7 Technologies vs. Advanced Braking Technology | Mach7 Technologies vs. Event Hospitality and | Mach7 Technologies vs. Ras Technology Holdings |
Telix Pharmaceuticals vs. Infomedia | Telix Pharmaceuticals vs. Home Consortium | Telix Pharmaceuticals vs. COAST ENTERTAINMENT HOLDINGS | Telix Pharmaceuticals vs. Australian Unity Office |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |